at://
/
app.bsky.feed.post
/
3mnaupitei22b
sign in
All
4
Record
2
Post
1
PostEmbed
1
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
PostEmbed
Dr Marlana Orloff speaks to ecancer about the phase 2/3 OptimUM-02 trial. This trial evaluates darovasertib (PKC inhibitor) combined with crizotinib (MET inh
ecancer.org
Darovasertib plus crizotinib improves outcomes in HLA-A2–negative metastatic uveal melanoma - ecancer
